Nicklas J. Johansen

Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial

Nicklas J. Johansen, Thomas F. Dejgaard, Asger Lund et al. · The Lancet Diabetes & Endocrinology · 2020 · 61 citations

Nutrition, Type 1, Short-acting Exenatide +9

Effects of short‐acting exenatide added three times daily to insulin therapy on bone metabolism in type 1 diabetes

Nicklas J. Johansen, Thomas F. Dejgaard, Asger Lund et al. · Diabetes Obesity and Metabolism · 2021 · 17 citations · Full text

Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled Trial

Casper K. Nielsen, Caroline C. Øhrstrøm, Inas J.K. Houji et al. · Diabetes Care · 2023 · 13 citations · Full text

Effect of short‐acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double‐blind placebo‐controlled trial

Nicklas J. Johansen, Thomas F. Dejgaard, Asger Lund et al. · Diabetes Obesity and Metabolism · 2020 · 10 citations